Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Classification and Physiology
  • Track 1-2Structure and Morphology
  • Track 1-3Different types of fungal infections
  • Track 1-4Genetic and Biochemical properties
  • Track 1-5Mycotoxicology
  • Track 1-6Veterinary Mycology
  • Track 1-7Environmental Mycology
  • Track 1-8Phytomycology

  • Track 2-1Aspergillosis and Blastomycosis
  • Track 2-2Candidiasis and Candida auris
  • Track 2-3Coccidioidomycosis (Valley Fever)
  • Track 2-4Talaromycosis and C. neoformans Infection
  • Track 2-5Ring worm and Mucormycosis
  • Track 2-6Fungal Eye Infections
  • Track 2-7Chronic and destructive fungal infections
  • Track 2-8Other Fungal Diseases

  • Track 3-1Types of Opportunistic Fungi
  • Track 3-2Filamentous Fungi and Cryptococcosis
  • Track 3-3Opportunistic Fungal Pathogens
  • Track 3-4Invasive fungal infections
  • Track 3-5Subcutaneous Mycoses
  • Track 3-6Superficial and Cutaneous Mycoses
  • Track 3-7Clinical manifestations and epidemiology
  • Track 3-8Immunity and Pathogenesis

  • Track 4-1Allergic Bronchopulmonary Aspergillosis
  • Track 4-2C. gattii Infection
  • Track 4-3Fungal Nail Infections
  • Track 4-4Talaromycosis
  • Track 4-5Dermatomycoses
  • Track 4-6Tinea Versicolor
  • Track 4-7scalp infections
  • Track 4-8Pathogenesis of Mycosis fungoides
  • Track 4-9Subcutaneous Mycoses
  • Track 4-10Deep Mycoses
  • Track 4-11Mycromycosis
  • Track 4-12Dermatophytic reaction
  • Track 4-13Contagious skin infection
  • Track 4-14Body ring worms
  • Track 4-15Derma pathology

 

 

  • Track 5-1Root causes of infections
  • Track 5-2Invasive Fungal Infections
  • Track 5-3Nosocomial Fungal Infections
  • Track 5-4Fungal Skin Infections
  • Track 5-5Genomic Epidemiology
  • Track 5-6Disease Predisposition

 

 

 

  • Track 6-1Diagnosis of invasive fungal disease (IFD)
  • Track 6-2Histopathology Techniques
  • Track 6-3Serologic tests
  • Track 6-4Microscopic Examination
  • Track 6-5Non-Culture-Based Molecular Diagnostic Methods
  • Track 6-6Culture-Based Molecular Diagnostic Methods
  • Track 6-7Molecular and Nonmolecular Diagnostic Methods
  • Track 6-8New strategies for rapid detection of fungal infections

 

 

  • Track 7-1Anti Fungal Drugs
  • Track 7-2Mechanisms of Antifungal Resistance
  • Track 7-3Drug Combinations
  • Track 7-4Antifungal Immunotherapy
  • Track 7-5Pharmacology
  • Track 7-6Antifungal drugs and Side effects
  • Track 7-7Antifungal medicines for children
  • Track 7-8Natural treatment Methods
  • Track 7-9Preventive measures

 

 

  • Track 8-1Increasing risk of biodiversity loss by Fungi
  • Track 8-2Mechanisms of disease-induced extinction
  • Track 8-3Fungal pathogens
  • Track 8-4Fungal infections
  • Track 8-5Factor of Emergence
  • Track 8-6Discovery and Spread
  • Track 8-7Phenomenology
  • Track 8-8Amphibian Chytridiomycosis
  • Track 8-9Predictive Modeling

 

 

  • Track 9-1Recombinent DNA technology
  • Track 9-2RNA Interferance technology
  • Track 9-3Recent research in Scedosporium prolificans
  • Track 9-4Challenges in identification
  • Track 9-5Fungal metabolites
  • Track 9-6Fungal Genomics

  • Track 10-1Applied Mycology
  • Track 10-2Fungal Biotechnology (Mycotechnology)
  • Track 10-3Marine Mycotechnology and biodiversity
  • Track 10-4Fungal bioactive metabolites
  • Track 10-5Environmental mycology
  • Track 10-6Fungi as food, fuel and fertilizer
  • Track 10-7Fungal pesticides and biological control